Triage
What does it mean in plain English?
In pharmacovigilance, triage is the fast, first-pass review every incoming adverse event report goes through the moment it arrives. Before anyone does a deep causality assessment, someone has to quickly figure out: is this serious? Is it something already known about, or something new? And how fast does it need to move?
That quick sort determines everything that happens next, including the regulatory clock. A serious and unexpected reaction can trigger an expedited reporting deadline of just days, while a mild, well-documented one gets logged on a much slower, routine timeline. Getting triage right, and fast, is what keeps genuinely urgent safety issues from getting buried in routine paperwork.
Sort the inbox
Every new report gets triaged fast. Hover each incoming case to see which lane it lands in and why.
Hover a case to see the callCommon Misconceptions
"Wait, so some reports just get sorted into a slow lane? Doesn't every side effect deserve the same urgent attention?"
Every report does get reviewed; triage decides the speed, not whether it matters. Treating a well-known, mild rash with the same urgency as an unexpected death report would actually slow the whole system down, burying the truly urgent cases under routine ones.
